Jason Zemansky
Stock Analyst at Bank of America Securities
(4.66)
# 856
Out of 5,096 analysts
478
Total ratings
52.8%
Success rate
13.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Zemansky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABOS Acumen Pharmaceuticals | Downgraded: Sell | $8 → $1 | $0.2101 | +375.96% | 16 | Oct 30, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | n/a | $74.95 | - | 40 | Oct 30, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $31 | $10.26 | +202.14% | 44 | Oct 30, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $406 | $322.75 | +25.79% | 13 | Oct 30, 2026 | |
| SNDX Syndax Pharmaceuticals | Reiterated: Buy | $23 | $13.65 | +68.50% | 37 | Oct 30, 2026 | |
| BIIB Biogen | Reiterated: Hold | $244 → $257 | $253.62 | +1.33% | 17 | Oct 29, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $71 | $50.39 | +40.90% | 32 | Oct 28, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Hold | $29 | $18.19 | +59.43% | 40 | Oct 20, 2026 | |
| CYTK Cytokinetics | Reiterated: Hold | $85 → $81 | $62.99 | +28.59% | 51 | Oct 19, 2026 | |
| EIKN Eikon Therapeutics | Reiterated: Buy | $32 | $5.31 | +502.64% | 5 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $543 → $533 | $430.36 | +23.85% | 28 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $214 → $207 | $112.58 | +83.87% | 53 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.44 | +309.84% | 21 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $21.07 | +85.10% | 17 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $17 | $11.04 | +53.99% | 17 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $12 | $11.04 | +8.70% | 12 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.55 | +287.10% | 5 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.9861 | +609.87% | 19 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $58.51 | n/a | 2 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $15 → $12 | $2.62 | n/a | 4 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $2.03 | n/a | 3 | Dec 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.91 | n/a | 2 | Nov 17, 2023 |
Acumen Pharmaceuticals
Oct 30, 2026
Downgraded: Sell
Price Target: $8 → $1
Current: $0.2101
Upside: +375.96%
BridgeBio Pharma
Oct 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $74.95
Upside: -
Kura Oncology
Oct 30, 2026
Reiterated: Buy
Price Target: $31
Current: $10.26
Upside: +202.14%
Ligand Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $406
Current: $322.75
Upside: +25.79%
Syndax Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $23
Current: $13.65
Upside: +68.50%
Biogen
Oct 29, 2026
Reiterated: Hold
Price Target: $244 → $257
Current: $253.62
Upside: +1.33%
Travere Therapeutics
Oct 28, 2026
Reiterated: Buy
Price Target: $71
Current: $50.39
Upside: +40.90%
Arcus Biosciences
Oct 20, 2026
Reiterated: Hold
Price Target: $29
Current: $18.19
Upside: +59.43%
Cytokinetics
Oct 19, 2026
Reiterated: Hold
Price Target: $85 → $81
Current: $62.99
Upside: +28.59%
Eikon Therapeutics
Oct 19, 2026
Reiterated: Buy
Price Target: $32
Current: $5.31
Upside: +502.64%
Oct 19, 2026
Reiterated: Hold
Price Target: $543 → $533
Current: $430.36
Upside: +23.85%
Oct 12, 2026
Reiterated: Buy
Price Target: $214 → $207
Current: $112.58
Upside: +83.87%
Oct 7, 2026
Reiterated: Buy
Price Target: $10
Current: $2.44
Upside: +309.84%
Sep 8, 2026
Reiterated: Buy
Price Target: $39
Current: $21.07
Upside: +85.10%
Aug 11, 2026
Reiterated: Hold
Price Target: $20 → $17
Current: $11.04
Upside: +53.99%
Aug 11, 2026
Reiterated: Sell
Price Target: $12
Current: $11.04
Upside: +8.70%
Jul 27, 2026
Reiterated: Buy
Price Target: $6
Current: $1.55
Upside: +287.10%
Feb 17, 2026
Reiterated: Buy
Price Target: $7
Current: $0.9861
Upside: +609.87%
Oct 30, 2024
Reiterated: Buy
Price Target: n/a
Current: $58.51
Upside: n/a
Mar 28, 2024
Reiterated: Sell
Price Target: $15 → $12
Current: $2.62
Upside: n/a
Dec 26, 2023
Reiterated: Sell
Price Target: $1
Current: $2.03
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $8.91
Upside: n/a